Literature DB >> 10442346

Possible interactions between dietary antioxidants and chemotherapy.

D Labriola1, R Livingston.   

Abstract

Many patients treat themselves with oral antioxidants and other alternative therapies during chemotherapy, frequently without advising their conventional health care provider. No definitive studies have demonstrated the long-term effects of combining chemotherapeutic agents and oral antioxidants in humans. However, there is sufficient understanding of the mechanisms of action of both chemotherapeutic agents and antioxidants to predict the obvious interactions and to suggest where caution should be exercised with respect to both clinical decisions and study interpretation. This article will describe these potential interactions and areas of concern, based on the available data. It will also suggest several potential courses of action that clinicians may take when patients indicate that they are taking or plan to use alternative therapies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442346

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  19 in total

1.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort.

Authors:  Heather Greenlee; Marilyn L Kwan; Lawrence H Kushi; Jun Song; Adrienne Castillo; Erin Weltzien; Charles P Quesenberry; Bette J Caan
Journal:  Cancer       Date:  2011-09-27       Impact factor: 6.860

3.  Is the combinational administration of doxorubicin and glutathione a reasonable proposal?

Authors:  Bo-Yu Shen; Chong Chen; Yang-Fan Xu; Jia-Jia Shen; Hui-Min Guo; Hao-Feng Li; Xi-Nuo Li; Dian Kang; Yu-Hao Shao; Zhang-Pei Zhu; Xiao-Xi Yin; Lin Xie; Guang-Ji Wang; Yan Liang
Journal:  Acta Pharmacol Sin       Date:  2018-09-14       Impact factor: 6.150

4.  Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.

Authors:  Hidenobu Fukumura; Motohiko Sato; Kyouhei Kezuka; Itaru Sato; Xianfeng Feng; Satoshi Okumura; Takayuki Fujita; Utako Yokoyama; Haruki Eguchi; Yoshihiro Ishikawa; Tomoyuki Saito
Journal:  J Physiol Sci       Date:  2012-03-06       Impact factor: 2.781

5.  Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells.

Authors:  Nnenna Adimora Finn; Melissa Lambeth Kemp
Journal:  Mol Biosyst       Date:  2011-12-01

Review 6.  Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.

Authors:  Akiko Nakayama; Karen P Alladin; Obianuju Igbokwe; Jeffrey D White
Journal:  Cancer Invest       Date:  2011-12       Impact factor: 2.176

7.  Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

Authors:  M Robyn Andersen; Erin Sweet; Kimberly A Lowe; Leanna J Standish; Charles W Drescher; Barbara A Goff
Journal:  J Altern Complement Med       Date:  2013-02-27       Impact factor: 2.579

8.  Potential of chemotherapy-herb interactions in adult cancer patients.

Authors:  Jeannine S McCune; Amy J Hatfield; Anne A R Blackburn; Patricia O Leith; Robert B Livingston; Georgiana K Ellis
Journal:  Support Care Cancer       Date:  2004-02-27       Impact factor: 3.603

9.  Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project.

Authors:  Heather Greenlee; Marilie D Gammon; Page E Abrahamson; Mia M Gaudet; Mary Beth Terry; Dawn L Hershman; Manisha Desai; Susan L Teitelbaum; Alfred I Neugut; Judith S Jacobson
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

10.  Alternative therapy and abnormal liver function during adjuvant chemotherapy in breast cancer patients.

Authors:  Jin-Hee Ahn; Sung-Bae Kim; Mi Ra Yun; Jung-Shin Lee; Yoon-Koo Kang; Woo Kun Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.